Literature DB >> 2299766

Inappropriate testing for diarrheal diseases in the hospital.

D L Siegel1, P H Edelstein, I Nachamkin.   

Abstract

To assess the degree to which routine stool cultures, ova and parasite examinations, and Clostridium difficile toxin assays may be inappropriately ordered on hospitalized patients, we conducted a retrospective study to determine the relative yield of these tests on specimens collected from outpatients and inpatients as a function of time after admission. During a 3-year period, only 1 of 191 positive stool cultures and none of the 90 ova and parasite examinations with positive results were from the group of patients who had stool specimens submitted after 3 days of hospitalization. Analysis of laboratory work load for a 1-year period showed that specimens from this patient group contributed nearly 50% of the more than 3000 specimens received each year. In contrast, approximately 25% (range, 17% to 33%) of samples, regardless of admission status, were positive for C difficile toxin. Eliminating routine stool cultures and ova and parasite examinations on hospitalized patients would significantly reduce hospital and patient costs without altering patient care. Nationwide, such a policy might achieve a cost savings of +20 to +30 million per year.

Entities:  

Mesh:

Year:  1990        PMID: 2299766

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  41 in total

1.  Selective criteria for the microbiological examination of faecal specimens.

Authors:  R A Bowman; J M Bowman; S A Arrow; T V Riley
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

Review 2.  Avoiding laboratory pitfalls in infectious diseases.

Authors:  T S Lo; R A Smego
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401

3.  Diarrhoea developing in hospital patients.

Authors:  R M McLoughlin; H J O'Connor
Journal:  Ir J Med Sci       Date:  2005 Jan-Mar       Impact factor: 1.568

4.  Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.

Authors:  S P Sambol; M M Merrigan; D Lyerly; D N Gerding; S Johnson
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Value of routine stool cultures in hospitalized patients with diarrhea.

Authors:  F Barbut; P Leluan; G Antoniotti; A Collignon; A Sédallian; J C Petit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

6.  Fecal lactoferrin screening assay for inflammatory bacterial diarrhea.

Authors:  I Nachamkin
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

7.  Cost and time savings following introduction of rejection criteria for clinical specimens.

Authors:  A J Morris; L K Smith; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

8.  Reducing Unnecessary and Duplicate Ordering for Ovum and Parasite Examinations and Clostridium difficile PCR in Immunocompromised Patients by Using an Alert at the Time of Request in the Order Management System.

Authors:  Caitlin C Otto; Susan L Shuptar; Philippe Milord; Connor J Essick; Reshma Nevrekar; Svetlana L Granovsky; Susan K Seo; N Esther Babady; Steven C Martin; Yi-Wei Tang; Melissa S Pessin
Journal:  J Clin Microbiol       Date:  2015-06-10       Impact factor: 5.948

9.  Detection of Clostridium difficile toxin by enzyme immunoassay, tissue culture test and culture.

Authors:  O Liesenfeld; F Saeger; H Hahn
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

10.  N-CDAD in Canada: results of the Canadian Nosocomial Infection Surveillance Program 1997 N-CDAD Prevalence Surveillance Project.

Authors:  M Hyland; M Ofner-Agostini; M Miller; S Paton; M Gourdeau; M Ishak
Journal:  Can J Infect Dis       Date:  2001-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.